Network origin in Karen Valentine first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
40
| Public Company | Biotechnology | 40 |
| Subsidiary | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Karen Valentine via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BG MEDICINE, INC. | Medical Specialties | Founder Corporate Officer/Principal | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| AMERICAN DG ENERGY INC | Building Products | Founder Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Chief Tech/Sci/R&D Officer Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal | |
| TECOGEN INC. | Electrical Products | Founder Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cancer Research Institute
 Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Medical/Nursing Services | Corporate Officer/Principal Chairman | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Doctorate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| Purdue University | College/University | Doctorate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Symphony Capital LLC
 Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Founder | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Symphony Dynamo, Inc.
 Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Symphony Icon, Inc.
 Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| IGNYTA INC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| PROTAGENIC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MINK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| AgenTus Therapeutics SA | Director/Board Member Chief Executive Officer | ||
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Founder |
Statistics
International
| United States | 44 |
| Germany | 2 |
| United Kingdom | 2 |
| Switzerland | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 13 |
| Finance | 5 |
| Producer Manufacturing | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 313 |
| Corporate Officer/Principal | 160 |
| Independent Dir/Board Member | 96 |
| Chairman | 62 |
| Founder | 61 |
Most connected contacts
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Anthony Evnin | 46 |
| Scott Braunstein | 26 |
| Ulf Arne Wiinberg | 26 |
| Peter Svennilson | 25 |
| Timothy Rothwell | 24 |
| John Hatsopoulos | 24 |
| Mohammed Malik | 24 |
| Timothy Wright | 20 |
| Tom Dechaene | 19 |
| Hyam Levitsky | 18 |
| Mark Kessel | 18 |
| Emma Reeve | 18 |
| Shalini Sharp | 17 |
| Richard Levy | 17 |
- Stock Market
- Insiders
- Karen Valentine
- Company connections
